Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant Glioblastoma

13 May 2021

Abstract excerpt

Background Glioblastoma (GBM) is the most aggressive intracranial tumor which can be divided into two subtypes based on status of isocitrate dehydrogenase (IDH). A small fraction of patients after receiving standard treatment can be long-term survivors (LTS). This study was designed to disclose the predictors and clinical implications associated with LTS in IDH wildtype and mutant GBM. Methods Patients who...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Metastases and Treatment
Share to Cancer, Hypoxia, and Metabolism
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34055603
DOI: 10.3389/fonc.2021.632663

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant GlioblastomaPMID 34055603Read ↗

Comprehensive molecular characterization of long-term glioblastoma survivors.Semantic proximity Read ↗

Molecular profiling of long-term IDH-wildtype glioblastoma survivors.Semantic proximity Read ↗

Predicting short-term recurrence and identifying key risk factors in elderly glioma patients: Insights from a retrospective cohort study.Semantic proximity Read ↗

Do Long-Term Survivor Primary Glioblastoma Patients Harbor IDH1 Mutations?Semantic proximity Read ↗

[Analyses of IDH1 mutation and MGMT promoter methylation status for 5 cases of long-term survivors with glioblastoma].Semantic proximity Read ↗

Molecular features of glioblastomas in long-term survivors compared to short-term survivors—a matched-pair analysisSemantic proximity Read ↗

Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastomaSemantic proximity Read ↗

An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survivalSemantic proximity Read ↗

Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status.Semantic proximity Read ↗

A prognostic model of newly diagnosed glioblastoma based on clinical characteristicsSemantic proximity Read ↗

Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.Semantic proximity Read ↗

Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.